Susan Rheingold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Susan rheingold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Susan Rheingold Today - Breaking & Trending Today

Penn Medicine, Philadelphia: Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children's Hospital of Philadelphia's Transformative, Personalized Cancer Therapy | India Education | Latest Education News | Global Educational News

Penn Medicine, Philadelphia: Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children's Hospital of Philadelphia's Transformative, Personalized Cancer Therapy | India Education | Latest Education News | Global Educational News
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

New York , United States , Emily Whitehead , Stephan Grupp , Bruce Levine , Jodi Fischer Horowitz , Susan Rheingold , Cara Cusumano , David Porter , Ross Kauffman , Penn Medicine Abramson Cancer Center , Abramson Cancer Center , Stephenp Kelly Center , Tribeca Film Festival , New York City , Robin Honan , Carl June , Penn Medicine , Abramson Cancer , Tumor Vanished , Film Festival Director Cara Cusumano , Edward Netter Professor , Cancer Gene Therapy , Founding Director , Clinical Cell , Vaccine Production Facility ,

Allterum Therapeutics completes Series Seed offering, builds team with addition of Philip Breitfeld as Chief Medical Officer


Allterum Therapeutics completes Series Seed offering, builds team with addition of Philip Breitfeld as Chief Medical Officer
News provided by
Share this article
Share this article
HOUSTON, Dec. 17, 2020 /PRNewswire/  Allterum Therapeutics, Inc. completed its $1.8 million Series Seed offering to members of the FanninDirect
SM investor group.  Allterum is developing a novel immunotherapy for treatment of IL7R-expressing cancers, including difficult to treat cases of pediatric acute lymphoblastic leukemia (ALL), a program which has received both Orphan Drug and Rare Pediatric Disease Designations from FDA. The company will use the proceeds for its pre-clinical antibody manufacturing and toxicology work and to continue to build the management team. ....

United States , Serena Miggins , Philipp Breitfeld , Product Development , National Cancer Institute , Eric Schafer Baylor College Of Medicine , Therapeutic Centers Of Excellence , Allterum Therapeutics Inc , Cancer Prevention Research Institute Of Texas , Allterum Therapeutics , Series Seed , Orphan Drug , Rare Pediatric Disease Designations , Global Vice President , Therapeutic Centers , Chief Medical , Scott Durum , Atul Varadhachary , Allterum President , Therapeutics Advances , Childhood Leukemia , Eric Schafer , Baylor College , Texas Children , Susan Rheingold , Investigational New Drug ,